HIV Prevention Trials Network   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Durham NC United States (2000)

Organization Overview

First Clinical Trial
2005
NCT00074425
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

HIV Prevention Trials Network

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 2)

Communicable Diseases (Phase 2)

HIV Infections (Phase 3)

Infections (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 15